Adjuvant trastuzumab for breast cancer: the other side of the coin.
Gopalakrishnan
Somasundari
S
Linnane
John
J
D000911:Antibodies, Monoclonal / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics*; D001943:Breast Neoplasms / Q000191:economics*; D017024:Chemotherapy, Adjuvant / Q000191:economics; D016527:Drug Costs; D005260:Female; D005380:Financing, Government; D006801:Humans; D000068878:Trastuzumab; D006113:United Kingdom
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab